Jul
16
Johnson & Johnson’s Sales Slide 11% During the Pandemic
Posted in: UncategorizedJohnson & Johnson’s worldwide year-over-year sales declined 10.8% in the second quarter of 2020, as fewer consumers had elective surgery or opted to buy beauty products during the pandemic. The company’s medical device segment dropped 33.9% to $4.3 billion, while its consumer health division, which includes skin care brands Neutrogena and Aveeno, fell 7% to…
Post a Comment